Recurrent pediatric thrombosis: The effect of underlying and/or coexisting factors

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 5, 2012, Pages 434-439

  Gokce, Muge ^a   Altan, Ilhan ^a   Unal, Sule ^a   Kuskonmaz, Bars ^a   Aytac, Selin ^a   Cetin, Mualla ^a   Tuncer, Murat ^a   Gumruk, Fatma ^a   Gurgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

pediatric thrombosis; postthrombotic syndrome; recurrent thrombosis; thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 8; D DIMER; LOW MOLECULAR WEIGHT HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL OBSERVATION; CONGENITAL HEART DISEASE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFANT; INTRACARDIAC THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEDIATRICS; POSTTHROMBOSIS SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS PREVENTION; TURKEY (REPUBLIC); VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANTICOAGULANTS; ASPIRIN; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FACTOR VIII; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART DEFECTS, CONGENITAL; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT; MALE; POSTTHROMBOTIC SYNDROME; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

EID: 84863316869     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283548e39     Document Type: Article

References (18)

1. Richardson MW, Alien GA, Monahan PE. Thrombosis in children: current perspective and distinct challenges. Thromb Haemost 2002; 88:900-911. (Pubitemid 36018774)
2. van Ommen CH, Heijboer H, Bnller HR, Hirasing RA, Heijamans HAS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139:676-681. (Pubitemid 33097433)
3. Unal S, Varan A, Yalçn B, Büyükpamukçu M, Gürgey A. Evaluation of thrombotic children with malignancy. Ann Hematol 2005; 84:395-399. (Pubitemid 40823354)
4. Tavil B, Ozyurek E, Gumruk F, Cetin M, Gurgey A. Antiphospholipid antibodies in Turkish children with thrombosis. Blood Coagul Fibrinolysis 2007; 18:347-352. (Pubitemid 46699412)
5. Chan AK, Deveber G, Monagle P, Brooker LA, Massicotte PM. Venous thrombosis in children. J Thromb Haemost 2003; 1:1443-1455.
6. Streif W, Andrew M, Marzinotto V, Massicotte P, Chan AK, Julian JA, Mitchell L. Analysis of Coumadin therapy in paediatric patients: a prospective cohort study of 319 patients. Blood 1999; 94:3007-3014. (Pubitemid 29512704)
7. Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA 2003; 290:1071-1074. (Pubitemid 37430448)
8. Legani C, Cosmi B, Cini M, Frascaro M, Guazzaloca G, Palareti G. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 2004; 124:504-510.
9. Nowak-Göttl U, Junker R, Kreuz W, Eckardstein AV, Kosch A, Nohe N, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97:858-862. (Pubitemid 32154265)
10. Manco-Johnson MJ. How I treat venous thromnosis in children. Blood 2006; 107:21-29. (Pubitemid 43053518)
11. Estepp JH, Smeltzer M, Reiss UM. The impact of quality and duration of Enoxaparin therapy on recurrent venous thrombosis in children. Pediatr Blood Cancer 2011. doi:10.1002/pbc.23396. [Epub ahead of print]
12. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 1:1251-1257. (Pubitemid 24062848)
13. Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum 2006; 55:850-855. (Pubitemid 44917456)
14. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ, Mountain States Regional Thrombophilia Group. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004; 351:1081-1088. (Pubitemid 39167512)
15. Simioni P, Prandoni P, Lensing AWA, et al. The risk of recurrent venous thromboembolism in patients with an Arg506Gln mutation in the gene for factor V (Factor V Leiden). N Engl J Med 1997; 336:399-403. (Pubitemid 27081902)
16. De Stafano V, Simioni P, Rossi E, Tormene D, Za T, Pagnan A, Leone G. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica 2006; 91:695-698. (Pubitemid 43799473)
17. Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, et al. Pediatric Coagulation Consortium: Low-dose tissue plasminogen activator thrombolysis in children. J Pediar Hematol Oncol 2003; 25:379-386. (Pubitemid 36569969)
18. Eischer L, Gartner V, Schulman S, Kyrle PA, Eichinger S, AUREC FVII Investigators. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Ann Hematol 2009; 88:485-490.